<SEC-DOCUMENT>0000950170-25-025635.txt : 20250224
<SEC-HEADER>0000950170-25-025635.hdr.sgml : 20250224
<ACCEPTANCE-DATETIME>20250224161510
ACCESSION NUMBER:		0000950170-25-025635
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250222
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250224
DATE AS OF CHANGE:		20250224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Terns Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001831363
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39926
		FILM NUMBER:		25657172

	BUSINESS ADDRESS:	
		STREET 1:		1065 EAST HILLSDALE BLVD., SUITE 100
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		650-525-5535 EXT.101

	MAIL ADDRESS:	
		STREET 1:		1065 EAST HILLSDALE BLVD., SUITE 100
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tern-20250222.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-02-24T13:25:48.6776+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:tern="http://www.ternspharma.com/20250222" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_ab0744d8-0997-4b4d-922e-5e961163291d" name="dei:EntityCentralIndexKey" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d">0001831363</ix:nonNumeric><ix:nonNumeric id="F_52cd19dd-a7db-43a7-98e9-646b16897307" name="dei:AmendmentFlag" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tern-20250222.xsd"/></ix:references><ix:resources><xbrli:context id="C_360c6477-b304-4491-8b17-0f0c9f083e0d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001831363</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-22</xbrli:startDate><xbrli:endDate>2025-02-22</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c70967a4-1d17-4fa8-a762-3b7c60b74ae0" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_8c75de18-09fb-469d-abd9-81e04e36c3d0" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">February 22, 2025</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4660f63e-b54a-4bff-8049-50cedc4e055a" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Terns Pharmaceuticals, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:20%;box-sizing:content-box;"/>
    <td style="width:18%;box-sizing:content-box;"/>
    <td style="width:41%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_1eff702f-ec66-4003-8d4b-85623946e5b4" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9cea1067-7f81-4b74-94a7-63f918a90a1e" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-39926</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_928dff88-0493-4de2-be25-546d890d2fcc" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">98-1448275</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_24b0341b-f459-4b42-b2f6-6d55d2bc58e8" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1065 East Hillsdale Blvd.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_059dcf90-aae3-44a2-b5a1-953bb04d476e" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Suite 100</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d63adb6f-d429-4324-ab3d-e2ea13c672f3" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Foster City</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_8dad07ae-3082-4815-aa03-c88d7e754ea9" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e0869e40-1644-4d5b-9e2f-9438090e545c" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">94404</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_f2997e3b-21b8-404e-af88-bc8f70c538a0" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(650)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_dc48cafa-bcbb-411b-a715-7494734a953a" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">525-5535</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_16a21a09-e9c7-4940-ac20-71f959a691dd" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityInformationFormerLegalOrRegisteredName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">N/A</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_41d829e8-2205-42e4-9291-6924e4d8dcc5" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_366004e0-f668-4e3e-bb72-61aaab635701" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_79a99c36-c2e9-458e-9150-01cabd9f0bb4" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7bfc4b59-e01d-447b-b5cb-0d2a88a92536" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:15%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_2c176ae5-4967-4da4-97ec-1915f3d2c864" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_3f844116-a866-4f61-951e-c3559a01081f" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TERN</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e097e316-f249-4965-92af-17292c23186b" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_16f372e2-269f-493a-a55e-90196c75faee" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;"><ix:nonNumeric id="F_1017d2ee-d26b-4382-8a0d-4d1208733681" contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Appointment of Andrew Gengos as Chief Financial Officer</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 22, 2025, Terns Pharmaceuticals, Inc. (&#8220;Terns&#8221;), Terns, Inc. and Andrew Gengos entered into an employment agreement (the &#8220;Gengos Agreement&#8221;) pursuant to which Mr. Gengos will serve as the Chief Financial Officer of Terns, effective as of February 24, 2025 (the &#8220;Start Date&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Gengos, age 60, previously served as the Chief Financial Officer and Chief Business Officer of Athira Pharma, Inc., a publicly-traded biopharmaceutical company, from May 2023 to October 2024. Prior to that, Mr. Gengos served as the Chief Business Officer at Cyteir Therapeutics, Inc., a former publicly-traded biopharmaceutical company, from February 2020 to February 2023. In addition, Mr. Gengos held Chief Executive Officer roles at ImmunoCellular Therapeutics and Neuraltus Pharmaceuticals, where he provided strategic and financial leadership across multiple therapeutic areas, including oncology and neurodegenerative disease. Earlier, Mr. Gengos was Vice President of Strategy and Corporate Development at Amgen for eight years. Mr. Gengos started his career at Morgan Stanley before moving on to McKinsey &amp; Co., where he advanced from associate to Senior Engagement Manager. Since January 2020, Mr. Gengos has served on the board of directors of Turn Therapeutics, a privately-held biopharmaceutical company. Mr. Gengos earned a B.S. in chemical engineering from the Massachusetts Institute of Technology and an M.B.A. from the UCLA Anderson School of Management.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Gengos has no family relationship with any of the executive officers or directors of Terns or any person nominated or chosen by Terns to become a director or executive officer. There are no transactions in which Mr. Gengos has an interest requiring disclosure under Item 404(a) of Regulation S-K.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Gengos Agreement, Mr. Gengos will receive a starting annualized base salary of $510,000, and is eligible to receive an annual cash bonus targeted at 40% of his annual base salary then in effect, with the actual amount of such bonus, if any, to be based upon the achievement of performance objectives established by the Board of Directors of Terns (the &#8220;Board&#8221;). For calendar year 2025, any annual bonus paid to Mr. Gengos will be pro-rated based on the Start Date. Mr. Gengos is also eligible to participate in the employee benefit plans of Terns, subject to the terms and conditions of such plans.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with the Gengos Agreement, the Board also approved the grant to Mr. Gengos, effective as of the Start Date, of a stock option to purchase 750,000 shares of common stock of Terns at an exercise price per share equal to the closing price per share of the common stock on The Nasdaq Global Select Market on the Start Date. The option award vests over a four-year period, with 25% of the shares underlying the award vesting on the first anniversary of the Start Date and the remaining 75% of the shares underlying the award vesting monthly over the subsequent three-year period, subject to Mr. Gengos&#8217; continued employment by Terns. The option award is subject to the terms and conditions of the applicable award agreement and is being granted pursuant to the Terns 2022 Employment Inducement Award Plan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event of an Involuntary Termination, Mr. Gengos is entitled to receive the following benefits, in addition to any accrued obligations and subject to his timely execution and non-revocation of a general release of claims in favor of Terns: (i) continuation of his then-current annual base salary for a period of 12 months, (ii) a pro-rated portion of his annual performance bonus at 100% of target and (iii) continuation of his healthcare insurance coverage (or an equivalent reimbursement from Terns) for a period of 12 months.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, in the event of an Involuntary Termination within three months prior to or 12 months following a Change in Control (as defined in the Gengos Agreement), he is entitled to receive the following benefits, in addition to any accrued obligations and subject to his timely execution and non-revocation of a general release of claims in favor of Terns: (i) continuation of his then-current annual base salary for a period of 12 months, (ii) 100% of his annual performance bonus at 100% of target, (iii) full vesting acceleration of all his then-outstanding equity awards and (iv) continuation of his healthcare insurance coverage (or an equivalent reimbursement from Terns) for a period of 12 months.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Gengos Agreement defines an &#8220;Involuntary Termination&#8221; as a separation resulting from a termination without &#8220;cause&#8221; or a voluntary resignation by Mr. Gengos for &#8220;good reason&#8221;.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Gengos Agreement generally defines &#8220;cause&#8221; to mean the occurrence of any one or more of the following, subject to certain notice and cure rights: (i) the commission of any crime involving fraud, dishonesty or moral turpitude, (ii) the attempted commission of or participation in a fraud or act of dishonesty against Terns that results in (or might have reasonably resulted in) material harm to the business of Terns, (iii) the intentional, material violation of any contract or agreement between him and Terns or any statutory duty owed to Terns or (iv) conduct that constitutes gross insubordination or habitual neglect of duties and that results in (or might have reasonably resulted in) material harm to the business of Terns.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Gengos Agreement generally defines &#8220;good reason&#8221; to mean the occurrence of any one or more of the following, without his consent and subject to certain notice and cure rights: (i) a material diminution in his duties, authorities or responsibilities; provided, however, that good reason shall not be deemed to have occurred solely due to a change in his title, (ii) a reduction of greater than 10% in his annual base salary (as in effect on the effective date of the Change in Control transaction, if applicable); provided, however, that good reason shall not be deemed to have occurred in the event of a reduction in his annual base salary that is pursuant to a salary reduction program affecting all of the C-level officers of Terns and that does not adversely affect him to a greater extent than other C-level officers of Terns or (iii) a relocation of his primary business office to a location more than 30 miles from the location of his then-primary business office.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Gengos Agreement also obligates Mr. Gengos under standard invention assignment and confidentiality provisions.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Transition of Principal Financial Officer and Principal Accounting Officer Roles</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On the Start Date, in connection with the appointment of Mr. Gengos, Amy Burroughs ceased to serve as the principal financial officer of Terns and David Strauss ceased to serve as the principal accounting officer of Terns. Ms. Burroughs continues to serve as the Chief Executive Officer of Terns and a director on the Board. Mr. Strauss continues to serve as Vice President of Finance and Controller of Terns. As Chief Financial Officer of Terns, Mr. Gengos will act as both the principal financial officer and the principal accounting officer.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7.01 Regulation FD Disclosure.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 24, 2025, Terns issued a press release announcing the appointment of Mr. Gengos as Chief Financial Officer of Terns. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:90%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit<br/>No.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tern-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid #0000ee;font-kerning:none;min-width:fit-content;">Press Release issued by Terns Pharmaceuticals, Inc. on February 24, 2025.</span></a></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
    <td style="width:3%;box-sizing:content-box;"/>
    <td style="width:47%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TERNS PHARMACEUTICALS, INC.</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 24, 2025</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Elona Kogan</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Elona Kogan<br/>Chief Legal Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tern-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img52906712_0.jpg" alt="img52906712_0.jpg" style="width:175px;height:67px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:11.25pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Seasoned public company CFO with 25 years of leadership experience in biotech</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">FOSTER CITY, Calif., February 24, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (&#x201c;Terns&#x201d; or the &#x201c;Company&#x201d;) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced the appointment of Andrew Gengos as chief financial officer, effective immediately.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201c;We are delighted to have Andrew join the Terns&#x2019; team as our new chief financial officer, confident his extensive experience and proven track record of financial leadership will be instrumental in driving our growth. We look forward to Andrew&#x2019;s contributions as we continue to advance our mission to transform patients&#x2019; lives through the development of new medicines that have a valuable, enduring impact on human health,&#x201d; said Amy Burroughs, chief executive officer of Terns.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201c;I am pleased to be joining Terns as we advance our lead oncology and obesity programs towards compelling clinical readouts later this year,&#x201d; said Mr. Gengos. &#x201c;I look forward to working with the talented Terns&#x2019; leadership team to build on the Company&#x2019;s strong financial foundation and drive continued success in bringing new treatment options to patients battling serious diseases, including oncology and obesity.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Mr. Gengos is a seasoned finance and corporate strategy executive with 25 years of experience, successfully leading teams in the life sciences and biotechnology industry. Most recently, he served as the chief financial officer of Athira Pharma, Inc. Prior to that, Mr. Gengos was chief business officer at Cyteir Therapeutics, where he led the finance team that took the company public. In addition, Mr. Gengos held chief executive officer roles at ImmunoCellular Therapeutics and Neuraltus Pharmaceuticals, where he provided strategic and financial leadership across multiple therapeutic areas, including oncology and neurodegenerative disease. Earlier, Mr. Gengos was vice president of strategy and corporate development at Amgen for eight years. Mr. Gengos started his career at Morgan Stanley before moving on to McKinsey &amp; Co., where he advanced from associate to senior engagement manager. Mr. Gengos holds an M.B.A. from the UCLA Anderson School of Management and a B.S. in Chemical Engineering from the Massachusetts Institute of Technology.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">About Terns Pharmaceuticals</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns&#x2019; pipeline contains three clinical stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-&#x3b2; agonist, and a preclinical GIPR modulator discovery effort, prioritizing a GIPR antagonist nomination candidate. For more information, please visit: </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">www.ternspharma.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cautionary Note Regarding Forward-Looking Statements</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This press release contains forward-looking statements about the Company within the meaning of the federal securities laws. All statements other than statements of historical facts contained in this press release, including statements regarding the Company&#x2019;s strategy, future financial condition, future operations, future trial results, projected costs, prospects, plans, objectives of management and expected market growth, are forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. These statements are subject to risks and uncertainties that could cause the actual results and the implementation of the Company&#x2019;s plans to vary materially. For a detailed discussion of the risk factors that could affect the Company&#x2019;s actual results, please refer to the risk factors identified in the Company&#x2019;s SEC reports, including but not limited to its Annual Report on Form 10-K for the year ended December 31, 2023. Except as required by law, the Company undertakes no obligation to update publicly any forward-looking statements for any reason.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Contacts for Terns</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Investors</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Justin Ng</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0563c1;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">investors@ternspharma.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Media</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Jenna Urban</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">CG Life</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0563c1;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">media@ternspharma.com</font><font style="color:#ff0000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img52906712_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img52906712_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #  ?0# 2(  A$! Q$!_\0
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MJYB5;0QB:7\=_CA_P<%?\%3_ (V_:[1?VA$^$&A7:.C:#\#_  CX?\"?9]^
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M^(9?AQX+>=8C$L-Q9Z?:>+/%\KV]RWGNGVV;3[F.!+=YK5)IYK>T^K?V;_\
M@Y2_X)L?'G7K'PKXM\0?$?\ 9NUS4+A;.SO/CEX9TFP\%7-R^YHP?'/@KQ'X
MRT70[3RP/-U+QH?">GPS!XGN2I@EG_S<:*]6KP'D,Z3A"&*HSLTJT,1*4[]&
MXU%.F_-*$;J^J>J\*AXJ<54ZZJ5:F!Q%+F3>'J82$*?+UC&=&5.LG;:4JD[.
MS::NG_L_:-K.C^(M)TS7_#^JZ;KNA:U86FJZ-K6C7UKJ>DZMIE_ ES8ZCIFI
M64L]G?V%[;2QW%I>6LTMO<02)+#(\;JQTJ_S6_\ @BM_P6.^(?[ WQ5\,_!_
MXL^*-4\2?L;>.]>33O%/AW5);C4V^#FI:U<;%^(_@/S)&GTK3[34)DO/''AJ
MRWZ;K>DR:GJEMIK^*(;.ZE_TFK&^LM3LK/4M-O+74-.U"UM[ZPO[&XBN[*^L
MKN))[6\L[J!Y(+FUN8)(YK>XAD>*:)TDC=D96/Y?G^0XG(<5&C5DJU"LI2PV
M)C%QC5C%I2C*+;Y*L+QYX<TDE*,E)J2/V_A3BK!\4X&6)H0>'Q6'E&GC<'.:
MG*A.2;A.$TH^TH54I>RJ.$&W"<91C*#+5%%%>$?4A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "H;BWM[RWGM+N"&ZM;J&6WN;:XB2
M>WN+>=&BF@GAE5HYH9HV:.6*1621&9'4J2#-10FT[IV:U36Z?<32:::335FG
MJFGNFNJ9^2'[3_\ P1U_9J^.<U_XH^&9N?V=_B'=&>=]0\":=;77@+5+R179
M9=:^',D]AID/[U@\DGA*_P#"LL[-+->_;9G##^?/]HS_ ()__MD?LJB_U;QC
M\.9OB/\ #JP,LC?$OX4K>>+M"MK)&E87?B'28K.#Q7X5BB@2-[Z\UK1(="MI
MYEMK;7+UMKO_ &]T5^Q\&>.7'?!_LL.LPEG>64^6*P.:SJ5ITZ<;+DPV-N\3
M2]U*$(598BA3BDH4$?SUXB_1D\+O$'V^+EE,>&\YK<TWF>14Z6&IU:KUY\9E
MO*L%7O*\ZDZ,<)BJLFY3Q3;N?YVVE^,-%U5%:&ZC!;'&]2.?QSTZ\5TR2)(
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M&_"VB:MXC\0ZS<I9:3H>A:==ZMJ^IW<F3':Z?IMA%/=W=PP5F$4$,CE59MN
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M117GGK!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?S6_P#!<S_DJWP+_P"R>^(__4DCK\,:_<[_
M (+F?\E6^!?_ &3WQ'_ZDD=?AC7^HO@3_P FFX,_[ L;_P"K?,#_ !$^E%_R
M?KQ%_P"QCEG_ *S^4!1117ZV?@05^@G_  3&^"'_  NS]KCP E_:_:?#'PR:
M3XJ^)=Z;X77PG<VC>&[.0/&\$RWOC"[\/QW-G/@7.EIJ6 XC9:_/NOZA_P#@
MBY\$!X+^ _BGXS:I:&+6?C#XB-GH\LL;!U\%>!YKW2[22$NQ,8U#Q-<^)&G"
M1QK<P:?IDS/,B0>5^3>-W%?^J/AQGV,I5?9X_,Z2R++&GRS^M9I&=&K4IO=5
M,-@(XS%TVD[3P\5I>Z_>OHT\"?Z_^,/"V7UZ/MLJR6N^*,Z4H\U/ZCD<Z5>C
M2JQM:5'&YI/+LOJQ;5Z>+F];6?[,T445_EP?[?!1110 4444 ?Y!/Q$_:-_:
M%A^('CF&'X\?&:*&+QCXFBBBB^*'C>..*./6[U$CC1-<"HB* J(H"JH    %
M<=_PTE^T3_T7SXT_^'3\<_\ R]K^Y+7?^#4C]C?7]<UG7;G]HO\ :9AN=:U7
M4=6N(8)_A8((I]1NYKR6.$2?#UY/*229ECWN[[ -S,V2<K_B$Q_8Q_Z./_:>
M_P"__P *?_G=U^U1XRX848IRE=))_P"PS[+^Y_5GY7_FN?ASQLYR:C3LY2:_
MX4Z:T;TT]IY_AZ7_ (@O^&DOVB?^B^?&G_PZ?CG_ .7M'_#27[1/_1?/C3_X
M=/QS_P#+VOV*_P""XG_!)CX,?\$NO^&8/^%0_$CXG_$'_A>7_"ZO^$A_X61)
MX4?^R/\ A6?_  J7^R?[&_X1CP[H&/M__"P=3_M'[=]KS]BL?LWD8N/._(G]
ME+X2Z+\?/VH_V;/@5XDU+5-&\._&KX^_!WX2Z]J^B&T&M:5HOQ'^(GAWP=JF
MI:0;^VO+$:I8V.LSW6GF]M+JT%W%$;BVGAWQ-]%A,7EV-P$<RP].$L+*%:HI
M2H*,^6A.I3J>XX\UU*E-)=;)K1H^/S# 9QEF:SR;%U:D,?"IAZ4J<,4YP4\5
M3HU:*]I&?(TX5Z;;O:+;3V9E_P##27[1/_1?/C3_ .'3\<__ "]H_P"&DOVB
M?^B^?&G_ ,.GXY_^7M?V^_\ $)C^QC_T<?\ M/?]_P#X4_\ SNZ/^(3']C'_
M *./_:>_[_\ PI_^=W7S_P#KEPQ_-/\ \(9__(?U9^5_K?\ B'/&_P#+3_\
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M/_SNZO\ URX8_FG_ .$,_P#Y#^K/ROE_Q#GC?^6G_P"'.G_\L_JS\K_Q!?\
M#27[1/\ T7SXT_\ AT_'/_R]K[V_9+_X+7?\%$_V1=?TBX\-_M >+OBKX%L9
MH5U#X4_'/5]5^)_@S4=,CE\V72]/N/$-]<>*?!R.2[QW'@GQ!X?D6=BUPMU
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M%2.'QCA%1C64XN5#$J$?=@ZT8SC.$;156E4E",(2A"/\IW_!U?\ $#QY\/\
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MI&E3J8_%46XXGFKQ4Z.%H3C[U+]U*%6I4IM5)^TIPA*"C453W[QA^V/^UO\
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M%<4Y@LIRJI./O+)LDG..)JT9:6AC,WJXBA6CK>>44G=6L%%%%?RB?W<%%%%
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MS1=&MH!(9KC5=5O8+'3H(1$KRF6:[GACC$2-(78!%9L _P"SO7^<%_P;P_\
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M72J>[^[Q%.-:$;*FW_M"U_)!_P ';G_)NW[(W_9:?&__ *@T-?J%_P $1_\
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MT]%%%?+'W(4444 %%%% !1110 4444 %%%% !1110 4444 ?S6_\%S/^2K?
MO_LGOB/_ -22.OPQK]SO^"YG_)5O@7_V3WQ'_P"I)'7X8U_J+X$_\FFX,_[
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M>!-9M+;=KOA74WL_*U*Y\ZP:UN'\F25[>+\3J_T[/^#>7_E#W^R%_P!U^_\
M6H?C77[AQ;F^+R7+:&*P7LO:U,=2P\O:P=2/LY4,34=DI1M+FI1UOM=6UNOY
MAX X?R_B3.<3@<R]NZ%++*V+A["JJ4_:T\7@J,;R<9WCR5ZEXVU=G?0_E5_X
MA:?^"E__ $'OV8?_  Z?B[_YV%'_ !"T_P#!2_\ Z#W[,/\ X=/Q=_\ .PK_
M $3J*_//]?<^[X+_ ,)G_P#+?ZN_*WZ]_P 0IX5[9E_X6+_Y3_5WY6_SL?\
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M_P"4_P!7?E;_ ":/V^_^";G[27_!-[QIX"\%?M$6W@V>?XE>%[_Q1X3U_P
M:YJ7B+PQ?0Z1JKZ3K6CMJ6IZ#X>G77M&>32[W4K%+*6*#3]>T2X%T[WCQ0>?
M?L%_#OX&_%[]LG]G'X5?M):AXDTSX+_$?XI>'? _C&]\*:K:Z'J\<GBB9]&\
M,QOK-WIFKQ:7HMSXOO- M?$]^MI'<VOAF;5Y;+4M&O%@UBQ_NX_X.7OV4?\
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MG6%F2Y\6_".YG4%8&\+7-Y%?>$Q<!6O?!>H:9 EQJ.I:'K\\/^FG7Q?^W_\
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M<^?%OP!\>?V)/V"?C-\*_$-KXI^'GQ*^(7B+Q=X2UZTRJ7VD:O\ #VWN(1/
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M4]AC8+V-.::G@\?0Q-"56,HNSA"M3HRA5C9N%:G3:4>:JWM_L2?\GG_LB_\
M9SWP#_\ 5K>$Z_U\J_R#?V)/^3S_ -D7_LY[X!_^K6\)U_KY5\/XC_[SE?\
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MEXGTJUN;Y9)]6MKQ+2SE%OX9FB3^=O\ X)@ZSJVA?\%'_P!@Z^T6ZGM+R?\
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M!_B)]*+_ )/UXB_]C'+/_6?R@*_=C_@B-\$?[9\>_$SX^ZK9E['P7I,7P_\
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M[7PCX;UGQ)<V-M+X*BBBN+R#1K*]EMH))08XY9E2-Y 45BW%?QU_L[?L[?M
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MGE1RCRU8Y1AN; Y)1D[+FI3I0Q.:4'=^YFNK7PQ****_GH_K4**** "BBB@
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M6QN;^R@NR4_T>:[MXY=KRH"?L;30S_\ !5K]NMX)8YD70=7A9XG611-;^+O
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MLV@Z5X?0> M2T/2X;>TTJUFLU>"[N-&NM3CDNX)Y$NP+WRI%)0($+*9?@/\
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MH0V*3WD O# 99&6.-(E1%ZWX!_\ !/CP5\#]?\8ZKJ/Q:^,'QAT;QS\.]?\
MAKK_ (,^*WB"SU[PM<Z'XDO]%N]3F-A!86C&]EM]';3!*92HL-2U"+;NE5D_
M0&BBRO>RN!^-]_\ \$;/AE%)KNB>#_V@OCSX+^&7B2_-YJWPUT[7+&YT:XC=
MP7M)9)8(;74(X85CMK*XUS2M7O8H8HOMES?R*TC?IG\"_@?\/OV=?AEX>^$_
MPRTZYL/"WAY;J2.34+D7VKZKJ.H7,EYJ6LZU?B* 7NIZA=2M)-)'!;VT$2P6
M5A:V>GVMI:0>NT4));( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!\?\ BWX'GQQ^VI\+OC)JEF9-#^#?P;\2PZ3+)&?*D\<>-M>N=(T_
MRS)$T,XT[PU#XFN+A8G$]E>76B7)*"6,O]@445Z>8YMB\SIY91Q,KTLHRVGE
M6!@FVJ6%AB<5C)+7K4Q>-Q59Z*SJ\NJBF_%RC(L!DM;.\1@X6K\09S5SS,ZK
M23KXVI@\#ET):=*6 RW X:-V[JAS:<S2****\P]H**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
B**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>tern-20250222.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-02-24T13:25:48.9993+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.ternspharma.com/20250222" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:tern="http://www.ternspharma.com/20250222" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="tern-20250222.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information, Former Legal or Registered Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10200.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="10150.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46169477814992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 22, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 22,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Terns Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001831363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1448275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1065 East Hillsdale Blvd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Foster City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">525-5535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TERN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( .2!6%HZJJ+G0 $  #P"   /
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M-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$%     @ Y(%86B0>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( .2!6%IED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    " #D@5A:4!5V$.X    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #D@5A:
MF5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( .2!6%K;(@C=N@0  (\2   8              "
M@0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #D@5A:
MGZ ;\+$"  #B#   #0              @ ']#   >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( .2!6%J7BKL<P    !,"   +              "  =D/  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( .2!6%HZJJ+G0 $  #P"   /
M      "  <(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #D@5A:)!Z;
MHJT   #X 0  &@              @ $O$@  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " #D@5A:99!YDAD!  #/ P  $P
M    @ $4$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  !>
%%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tern-20250222.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tern-20250222.htm">tern-20250222.htm</File>
    <File>tern-20250222.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tern-20250222.htm": {
   "nsprefix": "tern",
   "nsuri": "http://www.ternspharma.com/20250222",
   "dts": {
    "inline": {
     "local": [
      "tern-20250222.htm"
     ]
    },
    "schema": {
     "local": [
      "tern-20250222.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 25
   },
   "report": {
    "R1": {
     "role": "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_360c6477-b304-4491-8b17-0f0c9f083e0d",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tern-20250222.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_360c6477-b304-4491-8b17-0f0c9f083e0d",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tern-20250222.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.ternspharma.com/20250222/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-25-025635-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-025635-xbrl.zip
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M6P2_@K'C6$21&),O8<QB/V01.:M&W08P_1;9BR)RBI]EY%1D(KT0O*4Z'>2
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M 5BR.Z [@=DVA$$-QPU ))J,,ML6U-5TU_';=L#$BDZ95[#_)D'O*<@?>V/
MN7%CX+V1T&%PC8#:!K&T4-J%<]E' Y!E4J& +(L3&4$O,B%;P<3+'">\LT_>
MS474/6"XVG*L:(R#7X8P--)O#!.!-ZFX"#/X+JBOI62^C[4HL3%>:LA9RC.5
MW<27A>_-35:'[YLRK_40+M'T-C>$H-QP\':[CD$[3./@-.J&UFF;IM-Y<-9#
MR257YS725/W\Y]\[>Z3"P=.!GL5WLKWLK$?</I9!;C23^X).[P8!K(MOL LB
M<45YF"J*Q>V=8ACO5K=$XMOY2^[^761Y&(PKB&0K"EQVS>UWD[V_01T(*M=
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M ;4R_B5J$9F4/AVZD],,(FW11!TD'"F"BQ, @Z$DP'#=(,E ;GCCLBFPK2>
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MPI(6"MUD$97VXK14L P#8'C:'-\4L60Z\-FKKXT4*I"1PH[Y[,!RVS>EX(:
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M4$L! A0#%     @ Y(%86DN9_ G<'0  .N4  !$              ( !
M '1E<FXM,C R-3 R,C(N:'1M4$L! A0#%     @ Y(%86B8(@CS]"   9FD
M !$              ( !"QX  '1E<FXM,C R-3 R,C(N>'-D4$L! A0#%
M  @ Y(%86J^KU;F("@  1S0   \              ( !-R<  '1E<FXM97@Y
=.5\Q+FAT;5!+!08      P # +L   #L,0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>tern-20250222_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tern-20250222.xsd" xlink:type="simple"/>
    <context id="C_360c6477-b304-4491-8b17-0f0c9f083e0d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001831363</identifier>
        </entity>
        <period>
            <startDate>2025-02-22</startDate>
            <endDate>2025-02-22</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_ab0744d8-0997-4b4d-922e-5e961163291d">0001831363</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_52cd19dd-a7db-43a7-98e9-646b16897307">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_c70967a4-1d17-4fa8-a762-3b7c60b74ae0">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_8c75de18-09fb-469d-abd9-81e04e36c3d0">2025-02-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_4660f63e-b54a-4bff-8049-50cedc4e055a">Terns Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_1eff702f-ec66-4003-8d4b-85623946e5b4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_9cea1067-7f81-4b74-94a7-63f918a90a1e">001-39926</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_928dff88-0493-4de2-be25-546d890d2fcc">98-1448275</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_24b0341b-f459-4b42-b2f6-6d55d2bc58e8">1065 East Hillsdale Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_059dcf90-aae3-44a2-b5a1-953bb04d476e">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_d63adb6f-d429-4324-ab3d-e2ea13c672f3">Foster City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_8dad07ae-3082-4815-aa03-c88d7e754ea9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_e0869e40-1644-4d5b-9e2f-9438090e545c">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_f2997e3b-21b8-404e-af88-bc8f70c538a0">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_dc48cafa-bcbb-411b-a715-7494734a953a">525-5535</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_16a21a09-e9c7-4940-ac20-71f959a691dd">N/A</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_41d829e8-2205-42e4-9291-6924e4d8dcc5">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_366004e0-f668-4e3e-bb72-61aaab635701">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_79a99c36-c2e9-458e-9150-01cabd9f0bb4">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_7bfc4b59-e01d-447b-b5cb-0d2a88a92536">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_2c176ae5-4967-4da4-97ec-1915f3d2c864">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_3f844116-a866-4f61-951e-c3559a01081f">TERN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_e097e316-f249-4965-92af-17292c23186b">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_16f372e2-269f-493a-a55e-90196c75faee">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_360c6477-b304-4491-8b17-0f0c9f083e0d"
      id="F_1017d2ee-d26b-4382-8a0d-4d1208733681">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
